Commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs

Paulina Stehlik; Laura Rosella; David Henry

doi:10.1093/ije/dyx284

Commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs

Paulina Stehlik, Laura Rosella, David Henry

Institute for Evidence-Based Healthcare

Research output: Contribution to journal › Article › Research › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	362-367
Number of pages	6
Journal	International Journal of Epidemiology
Volume	47
Issue number	2
Early online date	29 Jan 2018
DOIs	https://doi.org/10.1093/ije/dyx284
Publication status	Published - 1 Apr 2018

Access to Document

10.1093/ije/dyx284Licence: Free to read

Cite this

@article{045e9d58be9547bfbd93a2f0e1097ec0,

title = "Commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs",

author = "Paulina Stehlik and Laura Rosella and David Henry",

year = "2018",

month = apr,

day = "1",

doi = "10.1093/ije/dyx284",

language = "English",

volume = "47",

pages = "362--367",

journal = "International Journal of Epidemiology",

issn = "0300-5771",

publisher = "OXFORD UNIV PRESS",

number = "2",

}

TY - JOUR

T1 - Commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs

AU - Stehlik, Paulina

AU - Rosella, Laura

AU - Henry, David

PY - 2018/4/1

Y1 - 2018/4/1

UR - http://www.scopus.com/inward/record.url?scp=85055075819&partnerID=8YFLogxK

U2 - 10.1093/ije/dyx284

DO - 10.1093/ije/dyx284

M3 - Article

C2 - 29390133

SN - 0300-5771

VL - 47

SP - 362

EP - 367

JO - International Journal of Epidemiology

JF - International Journal of Epidemiology

IS - 2

ER -

Commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs

Access to Document

Other files and links

Response to authors re commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs

Cite this

Commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs

Access to Document

Other files and links

Related Research Outputs

Response to authors re commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs

Cite this